Continuous population-level monitoring of SARS-CoV-2 seroprevalence in a large European metropolitan region.
Marc Emmenegger,
Elena De Cecco,
David Lamparter,
Raphaël PB Jacquat,
Julien Riou,
Dominik Menges,
Tala Ballouz,
Daniel Ebner,
Matthias M Schneider,
Itzel Condado Morales,
Berre Doğançay,
Jingjing Guo,
Anne Wiedmer,
Julie Domange,
Marigona Imeri,
Rita Moos,
Chryssa Zografou,
Leyla Batkitar,
Lidia Madrigal,
Dezirae Schneider,
Chiara Trevisan,
Andres Gonzalez-Guerra,
Alessandra Carrella,
Irina L Dubach,
Catherine K Xu,
Georg Meisl,
Vasilis Kosmoliaptsis,
Tomas Malinauskas,
Nicola Burgess-Brown,
Ray Owens,
Stephanie Hatch,
Juthathip Mongkolsapaya,
Gavin R Screaton,
Katharina Schubert,
John D Huck,
Feimei Liu,
Florence Pojer,
Kelvin Lau,
David Hacker,
Elsbeth Probst-Müller,
Carlo Cervia,
Jakob Nilsson,
Onur Boyman,
Lanja Saleh,
Katharina Spanaus,
Arnold von Eckardstein,
Dominik J Schaer,
Nenad Ban,
Ching-Ju Tsai,
Jacopo Marino,
Gebhard FX Schertler,
Nadine Ebert,
Volker Thiel,
Jochen Gottschalk,
Beat M Frey,
Regina R Reimann,
Simone Hornemann,
Aaron M Ring,
Tuomas PJ Knowles,
Milo A Puhan,
Christian L Althaus,
Ioannis Xenarios,
David I Stuart,
Adriano Aguzzi
Feb 09, 2023
Effective public health measures against SARS-CoV-2 require granular knowledge of population-level immune responses. We developed a Tripartite Automated Blood Immunoassay (TRABI) to assess the IgG response against three...